"Legacy sequel done right," wrote NBC Universal's Christopher Ikonomou. "Final Destination: Bloodlines ups the ante on all fronts, from performances and chemistry to its splatter and disaster.

Open justice, a cornerstone of the Australian legal system, ensures that justice is not only done but seen to be done. Public scrutiny of court proceedings fosters accountability and prevents misuse ...

Nottingham Forest are said to be among a number of clubs keeping tabs on Benfica striker Vangelis Pavlidis. The Reds are in need of a front man this summer. Adding to their attacking resources ...

(Fichajes - in Spanish), external Chelsea and Newcastle United are interested in 26-year-old Benfica and Greece forward Vangelis Pavlidis for 100m euros (£85m), but face competition from ...

After recording a hat-trick in a resounding 4-1 win away to Porto, Vangelis Pavlidis has written his name into Benfica folklore. Vangelis Pavlidis has been one of SL Benfica's star performers this ...

Scotland travel to Athens to take on Greece in the first leg of their Nations League play-off on Thursday night, with Steve Clarke’s side looking to stay in the top tier of the competition.

Elsewhere in the Goalscorers market, Greece's Fotis Ioannidis and Vangelis Pavlidis are both the best-backed to score first at 5/1. Pavlidis in particular has been in strong form in front of ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. All the answers here are linked in some way. Once you’ve spotted the connection, any you didn’t know ...

Louisville basketball has three commitments in the Class of 2025: Mikel Brown Jr., Mouhamed Camara and Sananda Fru. Below, you'll find a breakdown of their games, including highlights. Considering ...

Greece deservedly took the lead after the break, as Vangelis Pavlidis was allowed to twist away from three England players in the box and drill a low strike beyond Jordan Pickford. Giorgos ...

The problem, notes UB faculty member Laertis Ikonomou, is that many of these interventions have scant proof of efficacy or safety. “While there have been efforts to regulate the stem cell market in ...

The problem is that many of these interventions have scant proof of efficacy or safety, noted Laertis Ikonomou, Ph.D., associate professor of oral biology in the University at Buffalo School of ...